Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
The Oncologist|June 10, 2025
Ultrasound-guided core needle biopsy of nodular lesions of the spleen in hematology clinical practiceAlessandro Broccoli, Sofia Maria Bakken, Lisa Argnani, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 7, 2023
Genomic Profiling of Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System Suggests Novel Potential Therapeutic TargetsClaudio Agostinelli, Luca Morandi, Simona Righi, et al.
European Journal of Haematology|September 19, 2024
Efficacy and Safety of Frontline Single-Agent Rituximab in Extranodal Marginal Zone LymphomaCamilla Mazzoni, Lisa Argnani, Beatrice Casadei, et al.
Annals of Hematology|June 4, 2025
SARS-CoV-2 infection does not affect the outcome of patients with relapsed/refractory large B-cell lymphoma treated with CAR T-cell therapyMarianna Gentilini, Beatrice Casadei, Cinzia Pellegrini, et al.
Leukemia & Lymphoma|October 10, 2009
Cyclophosphamide, doxorubicin, vincristine, methotrexate, bleomicin and prednisone plus rituximab in untreated young patients with low-risk (age-adjusted international prognostic index 0-1) diffuse large B-cell lymphomaEnrico Derenzini, Vittorio Stefoni, Cinzia Pellegrini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2009
Role of [18F]fluorodeoxyglucose positron emission tomography scan in the follow-up of lymphomaPier Luigi Zinzani, Vittorio Stefoni, Monica Tani, et al.
Cancers|October 13, 2021
Real World Evidence of CAR T-Cell Therapies for the Treatment of Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: A Monocentric ExperienceBeatrice Casadei, Lisa Argnani, Serafina Guadagnuolo, et al.
Hematological Oncology|October 31, 2012
Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective studyPier Luigi Zinzani, Cinzia Pellegrini, Emanuela Merla, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 28, 2019
Correction: Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specifiedMaria Antonella Laginestra, Luciano Cascione, Giovanna Motta, et al.
Annals of Hematology|December 25, 2019
Clinical characteristics of interim-PET negative patients with a positive end PET from the prospective HD08-01 FIL studyLuigi Rigacci, Benedetta Puccini, Alessandro Broccoli, et al.
Pageof 12